Source link : https://newshealth.biz/health-news/first-survival-win-for-cdk4-6-inhibitors-in-high-risk-early-breast-cancer/
(MedPage Today) — BERLIN — For the first time in a phase III trial, adjuvant treatment with a CDK4/6 inhibitor significantly improved overall survival (OS) in high-risk early breast cancer, data reported here showed. Patients who received… Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118016 Author : Publish date : 2025-10-18 17:26:00 Copyright for syndicated content belongs to the […]
The post First Survival Win for CDK4/6 Inhibitors in High-Risk Early-Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-18 17:26:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8